Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04888416 · ClinicalTrials.gov registry record · NA

Implementing Outcome Measures in Stroke Rehabilitation

A NA study of Stroke and Hemiparesis, sponsored by Ohio State University.

Active
Registry status
NA
Development phase
484
Enrollment target
1
Study location

NCT04888416: Active NA study of Stroke and Hemiparesis, sponsored by Ohio State University.

NCT04888416 is a NA study of Stroke and Hemiparesis that is active but no longer recruiting, run by Ohio State University. The registered enrollment target is 484 participants, below the 12,015-participant average among 454 other Stroke trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04888416, a NA study of Stroke and Hemiparesis, is active but no longer recruiting, sponsored by Ohio State University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
484 participants
Enrollment target
1
Study location

Study Summary

The primary objective of this study is to tailor and test implementation strategies to support the adoption of two upper extremity motor outcome measures for stroke: the Fugl-Meyer Assessment and the Action Research Arm Test. The study's interdisciplinary team will address this objective through the following specific aims: (a) Tailor a package of implementation strategies (referred to as I-STROM-Implementation STRategies for Outcome Measurement) to promote outcome measure use across the care continuum, (b) Determine the effectiveness of I-STROM on outcome measure adoption and (c) Evaluate the appropriateness, acceptability, and feasibility of I-STROM in rehabilitation settings across the country. The mixed-methods study design is informed by implementation science methodologies, and the tailoring of I-STROM will be guided by input from stakeholders, including occupational therapy practitioners and administrators. The investigators will collect robust quantitative and qualitative data by means of retrospective chart reviews, electronic surveys, and stakeholder focus groups. This study, "Strategies to Promote the Implementation of Outcome Measures in Stroke Rehabilitation," will address core barriers to outcome measure use through a package of implementation strategies, thus laying the groundwork for I-STROM scale-up in health systems nationwide.

Primary Outcome

Proportion of patients who are administered the outcome measures

Interventions

  • BEHAVIORAL I-STROM

Study Locations (1)

Ohio

  • The Ohio State University Wexner Medical Center - Columbus

Trial Details

FieldValue
Enrollment Target 484 participants
Start Date 2021-10-01
Est. Completion 2026-05-01
Phase NA
Ohio State University

552 total trials

What the registry record for NCT04888416 still lists

NCT04888416 is an interventional study that assigns participants to a tested intervention. The registered 484 participants enrollment target is mid-sized for trials with a published cap, below the 12,015-participant average among 454 other Stroke trials with a reported enrollment target (96% lower).

The record links to 5 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which I-STROM is the first listed.

NCT04888416 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT04888416 about?

NCT04888416 is a clinical study titled "Implementing Outcome Measures in Stroke Rehabilitation". The primary objective of this study is to tailor and test implementation strategies to support the adoption of two upper extremity motor outcome measures for stroke: the Fugl-Meyer Assessment and the Action Research Arm Test. The study's interdisciplinary team will address this objective through the...

What is the current status of trial NCT04888416?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 484 participants. The study started on 2021-10-01. Estimated completion is 2026-05-01.

What conditions does trial NCT04888416 study?

This clinical trial studies the following conditions: Stroke, Hemiparesis, Knowledge, Attitudes, Practice, Hemiplegia, Upper Extremity Dysfunction.

What interventions are being tested in trial NCT04888416?

The interventions under investigation include: I-STROM (BEHAVIORAL).

Who is sponsoring clinical trial NCT04888416?

This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04888416 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04888416's enrollment target sits among peer trials

484 60th of 454 higher than 395 of 454 other Stroke trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05421741 · 484 participants · Phase 4

    Prophylactic Antibiotic Coated Nail to Prevent Infection: A Clinical Trial

  • NCT07124910 · 485 participants · Phase 3

    Comparison of Epi-ON Corneal Collagen Crosslinking Performed Using an 18-Minute UVA Exposure vs. a 24-Minute UVA Exposure on Eyes With Ectatic Corneal Diseases

  • NCT02871726 · 483 participants · NA

    Transrectal Ultrasound Robot-Assisted Prostate Biopsy

  • NCT06420531 · 486 participants · NA

    Milk And Growth In Children (MAGIC) Born Very Preterm: A Randomized Trial

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04888416, the US trial registry maintained by the National Library of Medicine. NCT04888416 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.